Regado Biosciences, Inc. (extinct)

Regado Biosciences, Inc. (extinct)

Regado Biosciences, Inc. (extinct)

Overview
Date Founded

2001

Headquarters

120 MOUNTAIN VIEW BOULEVARD BASKING RIDGE NJ 07920

Type of Company

Private

Employees (Worldwide)

19

Industries

Pharmaceuticals

Company Description

Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a \"per patient, per setting\" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.

Contact Data
Trying to get in touch with decision makers at Regado Biosciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Regado Biosciences, Inc.
Potential Connections via
Relationship Science
You
Regado Biosciences, Inc.
Recent Transactions
Details Hidden

Regado Biosciences, Inc. purchases Tobira Therapeutics, Inc. (Inactive) from Frazier Healthcare Partners, Canaan Management, Inc., Domain Associates LLC, Montreux Equity Partners, Novo Ventures resulting in a new company Tobira Therapeutics, Inc.

Details Hidden

Regado Biosciences, Inc. issued Common Stock

Details Hidden

Regado Biosciences, Inc. raised money in a private placement transaction

Transaction Advisors
Underwriter

Advised onRegado Biosciences, Inc. issued Common Stock

Escrow Agent

Advised onRegado Biosciences, Inc. issued Common Stock

Auditor

Advised onRegado Biosciences, Inc. issued Common Stock

Legal Advisor

Advised onRegado Biosciences, Inc. purchases Tobira Therapeutics, Inc. (Inactive) from Frazier Healthcare Partners, Canaan Management, Inc., Domain Associates LLC, Montreux Equity Partners, Novo Ventures resulting in a new company Tobira Therapeutics, Inc.

Managing Director

Advised onRegado Biosciences, Inc. issued Common Stock

Legal Advisor

Advised onRegado Biosciences, Inc. purchases Tobira Therapeutics, Inc. (Inactive) from Frazier Healthcare Partners, Canaan Management, Inc., Domain Associates LLC, Montreux Equity Partners, Novo Ventures resulting in a new company Tobira Therapeutics, Inc.

Advisors & Consultants
Legal Advisor

Partner, Boston at Cooley LLP

Consultant

President, Chief Operating Officer & Director at Syndax Pharmaceuticals, Inc.

Consultant

Founder at ARG Consulting LLC

Key Stats and Financials As of
Market Capitalization
$792M
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden

Founder at Argos Therapeutics, Inc.

Details Hidden

Co-Founder at Regado Biosciences, Inc.

Details Hidden

President & Chief Executive Officer at Caladrius Biosciences, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Regado Biosciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Regado Biosciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Regado Biosciences, Inc..